CD105 promotes hepatocarcinoma cell invasion and metastasis through VEGF.

CD105 promotes hepatocarcinoma cell invasion and metastasis through VEGF.

Item
http://www.wikidata.org/entity/Q38950202
Transforming growth factor-beta1 suppresses hepatocellular carcinoma proliferation via activation of Hippo signalingPredictive values of serum VEGF and CRP levels combined with contrast enhanced MRI in hepatocellular carcinoma patients after TACE.C-met inhibition blocks bone metastasis development induced by renal cancer stem cells.Pigment epithelium-derived factor has a role in the progression of papillary thyroid carcinoma by affecting the HIF1α-VEGF signaling pathway.The earlier, the better: the effects of different administration timepoints of sorafenib in suppressing the carcinogenesis of VEGF in rats.Cancer Stem Cells, Bone and Tumor Microenvironment: Key Players in Bone Metastases.Bcl-2-associated athanogene 3(BAG3) is associated with tumor cell proliferation, migration, invasion and chemoresistance in colorectal cancerA comparison of CD105 and CD31 expression in tumor vessels of hepatocellular carcinoma by tissue microarray and flow cytometry
P2860

CD105 promotes hepatocarcinoma cell invasion and metastasis through VEGF.

Item
http://www.wikidata.org/entity/Q38950202
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
CD105 promotes hepatocarcinoma cell invasion and metastasis through VEGF.
@en
type
label
CD105 promotes hepatocarcinoma cell invasion and metastasis through VEGF.
@en
prefLabel
CD105 promotes hepatocarcinoma cell invasion and metastasis through VEGF.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P356
P1433
P1476
CD105 promotes hepatocarcinoma cell invasion and metastasis through VEGF.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698